APP Abraxane launch
American Pharmaceutical Partners' nanoparticle albumin-bound paclitaxel formulation Abraxane is scheduled to launch Feb. 8. The metastatic breast cancer treatment, which cleared FDA Jan. 7, is likely to be priced at a premium to Bristol-Myers Squibb's Taxol and Sanofi-Aventis' Taxotere based on safety and efficacy data...
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.